A Long Noncoding RNA Signature That Predicts Pathological Complete Remission Rate Sensitively in Neoadjuvant Treatment of Breast Cancer
BACKGROUND: Mounting evidence suggests that long noncoding RNAs (lncRNAs) are closely related to pathological complete response (pCR) in neoadjuvant treatment of breast cancer. Here, we construct lncRNA associated models to predict pCR rate. METHODS: LncRNA expression profiles of breast cancer patie...
Main Authors: | Gen Wang, Xiaosong Chen, Yue Liang, Wei Wang, Kunwei Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-12-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652331730270X |
Similar Items
-
Association of tumor‐infiltrating lymphocytes before and after neoadjuvant chemotherapy with pathological complete response and prognosis in patients with breast cancer
by: Jin Hong, et al.
Published: (2021-11-01) -
Association Between Background Parenchymal Enhancement and Pathologic Complete Remission Throughout the Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Chao You, et al.
Published: (2017-10-01) -
Both carboplatin and bevacizumab improve pathological complete remission rate in neoadjuvant treatment of triple negative breast cancer: a meta-analysis.
by: Xiao-song Chen, et al.
Published: (2014-01-01) -
A case of giant intrahepatic cholangiocarcinoma with pathological complete remission after neoadjuvant therapy
by: Xue Leng, et al.
Published: (2023-04-01) -
The C Allele of ATM rs11212617 Associates With Higher Pathological Complete Remission Rate in Breast Cancer Patients Treated With Neoadjuvant Metformin
by: Elisabet Cuyàs, et al.
Published: (2019-03-01)